Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands		Jun. 30, 2022	Dec. 31, 2021
Assets
Unrestricted cash and cash equivalents		$ 316,331	$ 409,660
Restricted cash and cash equivalents		49,989	96,968
Loans, interest and fees receivable:
Loans, interest and fees receivable, at fair value		1,616,875	1,026,424
Loans, interest and fees receivable, gross		104,563	470,293
Allowances for uncollectible loans, interest and fees receivable (including $55.1 million associated with variable interest entities at December 31, 2021)		(1,643)	(57,201)
Deferred revenue (including $8.2 million associated with variable interest entities at December 31, 2021)		(16,738)	(29,281)
Net loans, interest and fees receivable		1,703,057	1,410,235
Property at cost, net of depreciation		6,794	7,335
Operating lease right-of-use assets		12,264	4,016
Prepaid expenses and other assets		28,019	15,649
Total assets		2,116,454	1,943,863
Liabilities
Accounts payable and accrued expenses		46,971	42,287
Operating lease liabilities		19,764	4,842
Notes Payable, net held by VIEs		1,429,340	1,278,864
Senior notes, net		143,668	142,951
Income tax liability		47,694	47,770
Total liabilities		1,687,437	1,516,714
Commitments and contingencies (Note 10)
Shareholders' Equity
Common stock, no par value, 150,000,000 shares authorized: 14,561,078 and 14,804,408 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively		0	0
Paid-in capital		142,343	227,763
Retained earnings		147,853	60,236
Total shareholders’ equity		290,196	287,999
Noncontrolling interests		(979)	(500)
Total equity		289,217	287,499
Total liabilities, preferred stock and equity		2,116,454	1,943,863
Series A Preferred Stock [Member]
Liabilities
Preferred stock	[1]	40,000	40,000
Preferred stock	[1]	40,000	40,000
Series B Preferred Stock [Member]
Liabilities
Preferred stock		99,800	99,650
Preferred stock		99,800	99,650
Shareholders' Equity
Series B preferred stock, no par value, 3,188,533 shares issued and outstanding at June 30, 2022 (liquidation preference - $79.7 million); 3,188,533 shares issued and outstanding at December 31, 2021 (1)	[1]	$ 0	$ 0

[1] Both the Series A preferred stock and the Series B preferred stock have no par value and are part of the same aggregate 10,000,000 shares authorized.